IRF5 and neoplasm: In another report, Zhang et al. reported that infusions of nanoparticles formulated with mRNAs encoding IFN regulatory factor 5 (IRF5) in combination with IKKβ re-programs the immunosuppressive TAMs toward anti-tumor immunity, leading to induction of tumor regression [68].